@ElMonoGran42994 Avatar @ElMonoGran42994 El Mono Grande

El Mono Grande posts on X about $xbi, $guts, $ocul, $avbp the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [---] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 32.14% finance 5.36% currencies 4.46% cryptocurrencies 4.46% technology brands 2.68% countries 1.79% social networks 1.79%

Social topic influence $xbi #34, $guts 10.71%, $ocul #37, $avbp #14, $qure 7.14%, $vktx #116, in the 6.25%, market 5.36%, $slno 5.36%, sector #2211

Top accounts mentioned or mentioned by @biovalues @plainyogurt21 @biotechtradersd @balabioresearch @houndcl @adam7477882377 @richardtip17589 @prosperousguy @jfais20 @stmkrs @hall8jack @tradernorway @taeyoon43334145 @tweetawaydk @wexcapital @biomaven @kobeissiletter @marcperiu @monacobiotech @bingbingbom

Top assets mentioned Fractyl Health, Inc. (GUTS) Ocular Therapeutix, Inc. (OCUL) ArriVent BioPharma, Inc. (AVBP) uniQure N.V. (QURE) Viking Therapeutics, Inc (VKTX) Soleno Therapeutics, Inc. Common Stock (SLNO) AstraZeneca PLC (AZN) OnKure Therapeutics, Inc. (OKUR) Taraxa (TARA) CalciMedica, Inc. (CALC) Xenon Pharmaceuticals Inc (XENE) Kyverna Therapeutics, Inc. (KYTX) Alumis Inc. (ALMS) Upstream Bio, Inc. (UPB) Gain Therapeutics, Inc. (GANX) Werewolf Therapeutics, Inc. (HOWL) Pyxis Oncology, Inc. (PYXS) Passage (PASG) Context Therapeutics Inc. (CNTX) Oruka Therapeutics, Inc. Common Stock (ORKA) Relay Therapeutics, Inc. (RLAY) BioAtla, Inc. (BCAB) Acrivon Therapeutics, Inc. (ACRV) Terns Pharmaceuticals, Inc. (TERN) Ventyx Biosciences, Inc. (VTYX)

Top Social Posts

Top posts by engagements in the last [--] hours

"$xbi looks like Trump wetting the bed Bios below it"
X Link 2026-02-12T14:46Z [---] followers, [--] engagements

"$nktr wonder why non of the nekturds are commenting on the fact that metrics of monthly & quarterly are all over the place 🤷♂. Quarterly outperforming Monthly (maintaining EASI75) and vice versa (vIGA-AD 0/1) .going to be a challenge explaining to the fda what happened here"
X Link 2026-02-10T19:15Z [---] followers, [---] engagements

"$xbi biotech weak as fuck todaywith the exception of a few market scams. Basically biotech the weakest market sector of [----] so far.business as usual 🤷♂"
X Link 2026-02-10T21:03Z [---] followers, [---] engagements

"$xbi after yesterdays biotech sell off.of course today a new sell off. Business as usual in biotech hell"
X Link 2026-02-11T14:40Z [---] followers, [---] engagements

"All markets upbiotech down. All markets downbiotech further down. It makes no sense. $xbi lot of bs about the jobssure theyll keep rates up but economically it aint that related 🤷♂ damn"
X Link 2026-02-11T14:56Z [---] followers, [---] engagements

"$xbi biotech weakest sector again. Been that way since end of Oct 2025.3.5 months of weakness and countingbusiness as usual"
X Link 2026-02-12T15:02Z [---] followers, [---] engagements

"$ocul they have the dataif it is a missthey would have disclosed it now"
X Link 2026-02-13T22:28Z [---] followers, [---] engagements

"@plainyogurt21 @BalaBioResearch @houndcl I think difference with Rani trials is that in SOL-1 the front loading and selection of good responders creates an artificially inflated bcva baseline. This makes it easier to lose more than [--] letters in [--] months than a non-front loaded true sham group in [--] months"
X Link 2026-02-15T22:23Z [---] followers, [--] engagements

"@john_hersc79276 @Biomaven I doubt that very much if by actual SOC you mean Eylea HD.The label will be the label but all the other data (including [--] wk & further out) will inform its competitiveness. In the end it is all about preserving vision with the least injections possible and best safety profile"
X Link 2026-02-15T23:06Z [---] followers, [--] engagements

"$xbi crazy sell off.because why the fuck not.biotech business as usual. Most hated sector in the market"
X Link 2026-02-12T20:53Z [---] followers, [---] engagements

"$xbi nice methodical fadebusiness as usual"
X Link 2026-02-13T18:07Z [---] followers, [---] engagements

"$xbi giving it all back trash sector & trash sentiment 🤷♂🧐"
X Link 2026-02-13T19:01Z [---] followers, [---] engagements

"$xbi crap marketagain. Whats new.biotech 🤷♂"
X Link 2026-02-13T20:32Z [---] followers, [---] engagements

"@sharkbiotech What are these levels Either a miss or not. Superiority label or not.not that much grey. Of course delta size will matter a bit. But meeting the endpoint = revaluation"
X Link 2026-02-13T22:26Z [---] followers, [---] engagements

"@plainyogurt21 @BalaBioResearch @houndcl Just wondering if you factored in all other indications they are working on in your $ocul [--] usd BO And for failure rates of placebo you worked of the assumption that the [--] mg single dose preserves vision out to [--] months for 100% of pts. That seems way way too optimistic 🤷♂"
X Link 2026-02-15T16:18Z [---] followers, [---] engagements

"@KobeissiLetter Short sighted and left wing envy makes robbing the hard working middle class the new normal in the Netherlands"
X Link 2026-02-16T00:32Z [---] followers, [--] engagements

"@Marc_periu 15% already stat sig. Anything over [--] is home run"
X Link 2026-02-16T10:37Z [---] followers, [---] engagements

"$okur buying lottos here.some fuckery taking place in last minutes of trading"
X Link 2025-10-03T20:05Z [---] followers, [---] engagements

"$xbi the state of small & microcap biotech is terrible and doesnt point to a bull market whatsoever. [--] early stage bios with promising to good early data releases selling off 40+%.tell me this is the new normal in what some call a bio bull $ganx $howl $pyxs"
X Link 2025-12-18T21:46Z [---] followers, [----] engagements

"$avbp $kura $guts $xene $crvs $kytx Ridiculous sell off in the top [----] bio shitcos.my shitcos. It is what it is 🤷♂"
X Link 2026-01-05T16:40Z [---] followers, [---] engagements

"$pasg next on my shitco to short list 🙏😁 $cntx $tenx [--] of todays favorite shitco shorts 😂🙏 $cntx $tenx [--] of todays favorite shitco shorts 😂🙏"
X Link 2026-01-05T18:12Z [---] followers, [---] engagements

"$XBI schizophrenic market with all strong conviction being on fire sale $xene $fulc $tara $bbot ridiculous 😂😂😂🤷♂"
X Link 2026-01-12T18:30Z [---] followers, [---] engagements

"$xbi upof course plenty of shitcos that can only go down. Heavily discounted. Proof me wrong $espr $akba $ocul $tara because why the F not"
X Link 2026-01-14T18:47Z [---] followers, [---] engagements

"@plainyogurt21 So I guess $alms beat them to it.making $orka psoriasis dev an academic exercise 🤷♂"
X Link 2026-01-17T14:40Z [---] followers, [---] engagements

"@BioTechTraderSD @BioValues So now waiting for a pump attempt of this thrash co"
X Link 2026-01-21T17:47Z [---] followers, [---] engagements

"$xbi I must be in the shitco business. Everything I fucking touch is red today 😂😂 $slno $qure $pali $guts $vktx $vnda $fulc $ocul .all down. Somebody explain why bio index up 1% and which bio scams support it this time. Worst Stock Picker Of All Time wants to know 😂🤷♂ $xbi why is this cunt index so much up today and my shitco portfolio down. Which overvalued trash bios are pushing this up $xbi why is this cunt index so much up today and my shitco portfolio down. Which overvalued trash bios are pushing this up"
X Link 2026-01-21T19:04Z [---] followers, [----] engagements

"$slno $vktx $bbot $ocul $vnda shit stains barely moving"
X Link 2026-01-22T21:06Z [---] followers, [---] engagements

"$slno patiently waiting for BO that will come in 2026"
X Link 2026-01-23T16:05Z [---] followers, [---] engagements

"$avbp so huge drop on 1k and up a little on 6k.is that the manipulation today Cascade the stops This will explode so hard on data.you wont believe it 😁"
X Link 2026-01-23T16:34Z [---] followers, [---] engagements

"$avbp these shitcos giving back all gains.just like that"
X Link 2026-01-23T17:27Z [---] followers, [---] engagements

"$xbi giving it all back. Bioturds $avbp $ocul $rgnx $vktx $slno weak as fuck. Shorts are feasting today 😡"
X Link 2026-01-23T18:04Z [---] followers, [---] engagements

"$xbi double blow to my portfolio today both $calc and $rgnx hit by totally unexpected safety issues whilst on their way to key catalysts 🤷♂. This is why biotech can be so damn tricky and frustrating.even for seasoned investors"
X Link 2026-01-28T12:49Z [---] followers, [----] engagements

"$xbi bio liquidation day $rlay $kytx"
X Link 2026-01-28T16:54Z [---] followers, [---] engagements

"$guts expecting bad results Or simply no results 🤷♂ -13% is fierce"
X Link 2026-01-28T19:22Z [---] followers, [----] engagements

"$guts safe to say someone knew yesterday and sneak out. SEC should investigate. Funny to see that sham outperforms real world weight gain. Shitty result"
X Link 2026-01-29T12:21Z [---] followers, [---] engagements

"$guts around [--] cts/share cash left. Plenty of down side"
X Link 2026-01-29T12:38Z [---] followers, [---] engagements

"$qncx -11% random noise manipulation or parties sneaking through the back door $guts style"
X Link 2026-01-29T18:51Z [---] followers, [----] engagements

"Rampant shorting in mid & small caps. Amazing manipulation today $slno $ocul $vktx $qure $bbot all being killed 🤷♂.started liquidating today as this sentiment is piss poor"
X Link 2026-01-30T20:57Z [---] followers, [----] engagements

"$ocul $vktx $avbp fuck that shit"
X Link 2026-02-03T18:27Z [---] followers, [---] engagements

"@RichardTip17589 Did you make a ton already on your 60k $okur 😉"
X Link 2026-02-03T22:15Z [---] followers, [--] engagements

"@BioValues @BioTechTraderSD 0% upside & another 90% downside with no cash in a nanocap that will be trashed premarket on any early data release. Thats the kinda market we are in now"
X Link 2026-02-03T22:21Z [---] followers, [---] engagements

"@BioValues @BioTechTraderSD $bcab at [--] cts $acrv at [----] the kinda trash we are talking about. $guts is prima example of what will happen"
X Link 2026-02-03T22:23Z [---] followers, [---] engagements

"@BioValues @BioTechTraderSD It can trade as low as 30% of cash level as they have a high burn around [--] million per Q. Right now [--] million left. Can trade down to [--] million on data.so yeah maybe not 90% but a 50% drop is likely.will it spike on super early data.I think not"
X Link 2026-02-03T22:32Z [---] followers, [--] engagements

"@BioValues @RichardTip17589 @BioTechTraderSD Every failed biotech has a similar list 😂😂😂.try $qncx or $calc or $guts or "
X Link 2026-02-03T23:24Z [---] followers, [---] engagements

"@prosperousguy @monaco_biotech Not"
X Link 2026-02-04T14:06Z [---] followers, [---] engagements

"@Hall8Jack @prosperousguy @monaco_biotech Sure.but by that time every huntington patient would be on the $QURE treatment instead of being exposed to a trial. So hard to run a pivotal trial many years from now unless it generates exceptional data before"
X Link 2026-02-04T14:52Z [---] followers, [---] engagements

"$QURE I am gonna be so amused when they receive clearance to file for accelerated approval and this will fly passed [--] in a blink. I can only pray that many shorts havent covered by then 🤷♂🙏😁"
X Link 2026-02-04T14:54Z [---] followers, [----] engagements

"$avbp when p3 trial win Cash needed now"
X Link 2026-02-04T15:00Z [---] followers, [---] engagements

"@BioValues Stopped out of $okur already"
X Link 2026-02-05T16:54Z [---] followers, [---] engagements

"$qure cant wait for news that rips the face of all these shorting cuntswe are nearing judgement day"
X Link 2026-02-06T15:13Z [---] followers, [---] engagements

"@jfais20 In this market you need a successful p3 firstand even that may not be enough. Tons of microcaps having the same market disconnect (take $oncy for example)"
X Link 2026-02-06T23:06Z [---] followers, [--] engagements

"@BalaBioResearch The bet now is winner takes alland $tern has the better data set so far in metrics that matter most 🤷♂. But it is an interesting debate.analysts favor TERN. Think best waiting for updated data on both to make up my mind 😁"
X Link 2026-02-09T14:29Z [---] followers, [---] engagements

"@BalaBioResearch In a certain line it may be.and the market after that certain line may be very very small 🤷♂. They will both run pivotals in late line first. is there a market after that.probably.but maybe small. And unknown if pts post late line TERN-701 will respond 🤷♂"
X Link 2026-02-09T15:05Z [---] followers, [--] engagements

"@TraderNorway @taeyoon43334145 There are some similarities if you care to read the CRL.pay attention to the term natural history definitely not a positive for $qure"
X Link 2026-02-09T21:54Z [---] followers, [---] engagements

"@Liv4theBeat @TraderNorway @taeyoon43334145 Thats because FDA leadership is not what it used to be.thanks to Trump"
X Link 2026-02-09T23:39Z [---] followers, [---] engagements

"@plainyogurt21 $azn problem is not the $tecx problem"
X Link 2026-02-10T12:54Z [---] followers, [---] engagements

"$qure going to [--] or 75.tick tock tick tock"
X Link 2026-02-10T16:50Z [---] followers, [----] engagements

"$tecx thank you for playing. Obvious market overreaction.solid 40% gain and out for now 🙏 $tecx very close to virtual investors event. Perfect opportunity to set the record straight and clarify differences between $azn and $tecx trials pt pop and drugs.comfortable add at current depressed levels. Open market = tutes buying $tecx very close to virtual investors event. Perfect opportunity to set the record straight and clarify differences between $azn and $tecx trials pt pop and drugs.comfortable add at current depressed levels. Open market = tutes buying"
X Link 2026-02-10T17:02Z [---] followers, [---] engagements

"@Stmkrs I think not positive.but also not negative 🤷♂.but out for now. Ill wait till earnings or investors event for further confirmation. There is still so much upside even if it goes back to mid 20s"
X Link 2026-02-10T17:09Z [---] followers, [--] engagements

"@bingbingbom @matthewherper Prasad has no say in $avbp lead compound which is not in CBER territory"
X Link 2026-02-11T14:39Z [---] followers, [---] engagements

"@jfais20 $kura sitting at [--] EV now.same space"
X Link 2026-02-11T16:33Z [---] followers, [---] engagements

"@TweetAwayDK Bysanti will conservatively do [--] B in peak sales. At a 4x multiple this product by itself would carry a [--] B valuation (10x current valuation).if approved no other way but to go all-in 🤷♂"
X Link 2026-02-11T22:24Z [---] followers, [--] engagements

"$xbi biotech sucks these daysdid I already say that"
X Link 2026-02-12T17:07Z [---] followers, [---] engagements

"@bingbingbom $tecx trial success written in stone and $azn ditched its cardio asset so will be eyeing $tecx. That and insider buying does the trick"
X Link 2026-02-12T20:26Z [---] followers, [---] engagements

"@firebutworking @mickeychiku Wouldnt worry about it as youre not long 😂😂😂😂"
X Link 2026-02-14T23:12Z [---] followers, [---] engagements

"@Mello_Proto @KobeissiLetter Capital is carefully built by hard working middle class that put time and effort into putting money from income aside after it has been taxed already. Then the money is put at risk in return for a capital gain. Stealing part of it is unethical and in fact a robbery"
X Link 2026-02-16T00:37Z [---] followers, [--] engagements

"$xbi scammed up $fulc $avbp $vtyx $tara down big like wtf 🤷♂"
X Link 2026-01-06T19:06Z [---] followers, [---] engagements

"@cluelessbio @HOThomasWPhelps AA was underwhelming. Psoriasis: $alms will dominate. AD: maybe. Lupus: soooo much competitive products under dev. $nktr valuation is rich.where it is right now"
X Link 2026-01-27T14:47Z [---] followers, [---] engagements

"$mist approved product & trading at or below cash levels . Same as $kura and some others. Do not talk about overvaluation .please 🙏. It aint there. Bios are dirt cheap historically"
X Link 2026-02-06T01:41Z [---] followers, [---] engagements

"$tecx very close to virtual investors event. Perfect opportunity to set the record straight and clarify differences between $azn and $tecx trials pt pop and drugs.comfortable add at current depressed levels. Open market = tutes buying"
X Link 2026-02-10T13:53Z [---] followers, [----] engagements

"$ocul $vktx $qure [--] bio shitcos all heavily manipulatedeach for their own reasons but obvious to. Orders ready .lets rock 🫵🤟"
X Link 2026-02-10T20:29Z [---] followers, [----] engagements

"$upb stat sig but crap data"
X Link 2026-02-11T11:34Z [---] followers, [----] engagements

"$upb note to self: dont play a crap set up anymore $upb stat sig but crap data. $upb stat sig but crap data"
X Link 2026-02-11T11:37Z [---] followers, [----] engagements

"$vnda 5-10x value misappropriation if they get approval for their next product and filled pipeline full of p3 trials. This is so undervalued.already loaded but if the next pdufa leads to approval of yet another product I might go all-in. Already derisked as fuck 🤷♂"
X Link 2026-02-11T21:50Z [---] followers, [---] engagements

"$slno weak as fuck lately.new short report coming"
X Link 2026-02-12T15:28Z [---] followers, [---] engagements

"$vnda full trash mode on"
X Link 2026-02-12T15:36Z [---] followers, [---] engagements

"$crvs $nktr solid chatGPT summary of bear thesis rebuttal @Investorclimber @seedy19tron Here is ChatGPT summary and response to each claim regarding $CRVS ITK inhibitor #soqueltinib as unbiased as it can get link and conclusions below in post https://t.co/ReVqbAOP7s 2) Scientific veracity and logic argument-by-argument A. Engineered enrollment via biomarker @Investorclimber @seedy19tron Here is ChatGPT summary and response to each claim regarding $CRVS ITK inhibitor #soqueltinib as unbiased as it can get link and conclusions below in post https://t.co/ReVqbAOP7s 2) Scientific veracity and"
X Link 2026-02-12T17:28Z [---] followers, [---] engagements

"@plainyogurt21 @BalaBioResearch @houndcl Could be. But control could be av [--] L loss at [--] M (speculation on my part) and still be considered rescue free. But a 5L loss at [--] M impacts the 9M assumption for rescue free control. I cant see rescue free control at [--] M going beyond 25%not even in a group of responders🤷♂"
X Link 2026-02-15T17:28Z [---] followers, [---] engagements

"@grok from which exact trial comes the below slide related to wAMD and Lucentis"
X Link 2026-02-15T18:13Z [---] followers, [--] engagements

"@plainyogurt21 @BalaBioResearch @houndcl It depends what youre baseline is. But if you started at an inflated [--] letters baseline it is easier to lose [--] letters than when you start at a [--] baseline "
X Link 2026-02-15T23:01Z [---] followers, [--] engagements

"@plainyogurt21 @BalaBioResearch @houndcl And by [--] I mean baseline after pre loading & selection for super responders"
X Link 2026-02-15T23:11Z [---] followers, [--] engagements

"@Adam7477882377 [--] were newly posted on linkedin. I checked"
X Link 2026-02-15T23:02Z [---] followers, [--] engagements

"@Adam7477882377 @Marc_periu 50% =200%-300% upside"
X Link 2026-02-16T15:09Z [---] followers, [--] engagements

"$vktx looks like perfect storm: Roche with good news about their competitive drug & very bad bio sentiment & coupled with shorting HFs and traders. I will buy the shit out of this below [--]. Been waiting for days like this 🙏"
X Link 2026-01-28T17:51Z [---] followers, [----] engagements

"@WexCapital Youre right they roughly burnt through [---] million or thereabouts since inception. So little less than my ball park figure. Add a nice multiple and DCF that and you see what free cash SLNO should generate to make it a succesful venture"
X Link 2026-01-28T18:14Z [---] followers, [--] engagements

"$xbi -2% average bio ticker : -7% go figure. What keeps XBI up this time Probably the most hyped midcaps 🤷♂"
X Link 2026-01-28T20:51Z [---] followers, [---] engagements

"@jawwwn_ @peterthiel Pretty ridiculous statement. Just check out ASMLthe mightiest tech company in the world. Founded in the Netherlands. Without it USTech would not existthink about that"
X Link 2026-01-28T22:25Z [---] followers, [---] engagements

"$guts [--] strikes and youre out. Another blow. Lot of damage from [--] in a rowbut thats biotech for you 🤷♂ $xbi double blow to my portfolio today both $calc and $rgnx hit by totally unexpected safety issues whilst on their way to key catalysts 🤷♂. This is why biotech can be so damn tricky and frustrating.even for seasoned investors $xbi double blow to my portfolio today both $calc and $rgnx hit by totally unexpected safety issues whilst on their way to key catalysts 🤷♂. This is why biotech can be so damn tricky and frustrating.even for seasoned investors"
X Link 2026-01-29T12:25Z [---] followers, [----] engagements

"$guts I think they can shelf the obesity treatment. Not viable. 🤷♂. So expect it to trade around [--] cts or so given the number of shares outstanding"
X Link 2026-01-29T12:28Z [---] followers, [---] engagements

"$xbi biotech sentiment has changed. Every pop is sold. Any neutral or negative news and a ticker is slaughtered. -80% the new normal. Good news not rewarded. Meanwhile XBI relatively stable. Small caps and micro/nanocaps 30-50% below recent tops. We are in full correction mode"
X Link 2026-01-29T18:38Z [---] followers, [---] engagements

"$xbi $qncx $guts scam street doing it again. Another suspect leak another suspect case of insider trading 🤷♂. SEC wont do shit but the trading patterns are clear. $qncx -11% random noise manipulation or parties sneaking through the back door $guts style $qncx -11% random noise manipulation or parties sneaking through the back door $guts style"
X Link 2026-01-29T20:32Z [---] followers, [----] engagements

"@braden_tewinkel Some party or parties trading on insider knowledge. Happened to $guts and likely $qncx SEC wont investigate. No capacity small fish 🤷♂"
X Link 2026-01-29T21:06Z [---] followers, [---] engagements

"@Pharmdca In this climate you need very good news or youre butchered. I hope they realize that fluff news aint gonna cut it. Moving oral directly to p3 wouldnt be fluff btw. Ideally expect more on partnerships early stage programs with clear progress potential combo explorations"
X Link 2026-01-29T23:24Z [---] followers, [---] engagements

"$cort surprised it is holding up so well. Would expect this to dive sub [--]. Maybe tomorrow"
X Link 2026-01-30T00:01Z [---] followers, [---] engagements

"$xbi looks like another bad bio day coming in shitco territory. XBI wont reflect it though"
X Link 2026-01-30T11:50Z [---] followers, [---] engagements

"@jfais20 You could see this coming. US will be bypassed by the ROW more and more thanks to the isolationist and those that brought him to power 🤷♂"
X Link 2026-01-30T12:34Z [---] followers, [--] engagements

"$xbi relentless biotech pounding is starting to get annoying. If this continues I go in liquidation mode. Tons of shitcos below sp of [--] yr ago. Thats biotech in a bull market for you. Few hands full of companies did well over a [--] yr period. The rest barely moved or down"
X Link 2026-01-30T14:56Z [---] followers, [---] engagements

"@Quantumup1 Nobody cares what one hyped shitco does"
X Link 2026-01-30T14:57Z [---] followers, [--] engagements

"@RichardTip17589 @Quantumup1 Shitco analyst pumping shitco companyWS is crooked as F"
X Link 2026-01-30T19:01Z [---] followers, [--] engagements

"@RodLambertCPA It wasnt very smart of this management to pre-announce data release wks in advanceIt gives shorters a free pass. If you want to preserve value you announce Friday AH and present data Tuesday morning. This will cause a spike and if data is good a squeeze. But theyre amateurs 🤷♂"
X Link 2026-01-30T21:02Z [---] followers, [---] engagements

"@1nvestorGadget Most biotech down since end of Oct. $xbi long lost its relevance as reliable indicator of state of the market"
X Link 2026-01-30T21:39Z [---] followers, [--] engagements

"@dhruvaaya1 @Zwxsh Federer being the oldest player to hold top [--] position in rankings. Novak needs to perform another year at elite level to match that. Lets see how he does. In terms of GS Novak the best. But thats not the whole story"
X Link 2026-01-31T10:59Z [---] followers, [---] engagements

"@jfais20 I calculated XBI gains (140) if top [--] names performed according to the other [---]. Gain would have been 16%not too shabby but certainly nothing stellar (and dollar dropped quite a bit to so normalized returns even smaller). The broader biotech market (over 600) did far worse btw"
X Link 2026-02-03T23:58Z [---] followers, [--] engagements

"$ibb $xbi todays story is that of the past month amplified: buying big pharma and large midcap whilst obliterating all the rest.great bull market 😂😂😂"
X Link 2026-02-04T17:11Z [---] followers, [---] engagements

"@jeromeleonard5 Can we say bio bull market hasnt even startedtake top [--] outperformers away from XBI and you get a 16% performance for the other [---] xbi participants over 2025broader biotech (over [---] names) did far worse.we are only in the early innings of recovery.logically 🤷♂"
X Link 2026-02-04T22:22Z [---] followers, [--] engagements

"@DrEliDavid @SecRubio The absolute worst in the eyes of anyone outside of MAGA"
X Link 2026-02-04T23:06Z [---] followers, [--] engagements

"$vktx short everything into the ground. Default hedge fund modus in biotech these days 🤷♂ $xbi"
X Link 2026-02-05T14:16Z [---] followers, [---] engagements

"$xbi biotech being pounded since end of Oct [----]. Majority down by 20-50%. to hell with anybody talking about an amazing biotech bull market. Obviously only been paying attention to the few midcappers and some BP that were hyped and did well. All the rest: terrible performance"
X Link 2026-02-05T18:13Z [---] followers, [---] engagements

"@WexCapital You shouldnt be worried. Not about stuff I see or not see on twitter nor on my takes on VKTX or SLNO. We all have our darlings (admittedly VKTX is one of mine SLNO less so). And I do have a biotech background (albeit my MSc is from many years ago). Rest assured I do DD 🤷♂"
X Link 2026-01-28T18:27Z [---] followers, [---] engagements

"$ostx never pick a Friday.dumb assess $OSTX -0.74% today as OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully-Resected Pulmonary Metastatic Osteosarcoma More Info: https://t.co/KeWoqHe5vC https://t.co/TgDImCdY14 $OSTX -0.74% today as OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully-Resected Pulmonary Metastatic Osteosarcoma More Info:"
X Link 2025-10-10T14:24Z [---] followers, [---] engagements

"@Stmkrs CLDX trades at [--] x JSPR cap.if briq is as good as barzo sp will go through the roof. I would set my expectations a little lower. There is room for more than [--] player in this huge indication. Cash wont be a problem if on par with Barzo"
X Link 2026-01-08T09:58Z [---] followers, [---] engagements

"$xbi up. Biotech down $ocul $fate $caba fake index. No proxy for biotech"
X Link 2026-02-03T16:27Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing